Comment to a patient with SLC40A1-HC successfully treated using red blood cell apheresis

Med Mol Morphol. 2024 Mar;57(1):82. doi: 10.1007/s00795-023-00375-8. Epub 2023 Nov 27.

Authors

Yasuaki Tatsumi¹, Hisao Hayash², Koichi Kato³

Affiliations

¹ Department of Medical Biochemistry, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, 274-8510, Japan.
² Department of Medicine, Aichi Gakuin University School of Pharmacy, 1-100 Kusumoto-Cho, Chikusa-Ku, Nagoya, 464-8650, Japan.
³ Department of Medicine, Aichi Gakuin University School of Pharmacy, 1-100 Kusumoto-Cho, Chikusa-Ku, Nagoya, 464-8650, Japan. kkato@dpc.agu.ac.jp.

PMID: 38010478
DOI: 10.1007/s00795-023-00375-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Blood Component Removal*
Cation Transport Proteins / deficiency*
Erythrocytes
Hemochromatosis*
Humans
Iron Overload*
Mutation

Substances

Cation Transport Proteins

Supplementary concepts

Hemochromatosis, type 4